Five Prime Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on February 26
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Feb 7, 2019--Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developin…
